[Federal Register Volume 62, Number 247 (Wednesday, December 24, 1997)]
[Notices]
[Page 67395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33495]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings: National Advisory Allergy and Infectious Diseases Council; 
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology 
Subcommittee; Microbiology and Infectious Diseases Subcommittee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Allergy and Infectious Diseases Council, 
National Institute of Allergy and Infectious Diseases, and its 
subcommittees on February 2-3, 1998. Meetings of the Council, NAAIDC 
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious 
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be held at the National Institutes of Health, 
Bethesda, Maryland.
    The meeting of the full Council will be open to the public on 
February 2 in Building 31C, Conference Room 6, from 1 p.m. to 
approximately 3:30 p.m. for general discussion and program 
presentations.
    On February 3 the meetings of the NAAIDC Allergy and Immunology 
Subcommittee, NAAIDC Microbiology and Infectious Diseases Subcommittee 
will be open to the public from 8:30 a.m. until adjournment. The 
subcommittees will meet in Building 31C, conference rooms 8 and 6 
respectively.
    In accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the 
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee, 
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology 
and Infectious Diseases Subcommittee will be closed to the public for 
approximately four hours for review, evaluation, and discussion of 
individual grant applications. It is anticipated that this will occur 
from 8:30 a.m. until approximately 1 p.m. on February 2, in conference 
rooms 7, 8 and 6 respectively. The meeting of the full Council will be 
closed from 3:30 p.m. until recess on February 2 for the review, 
discussion, and evaluation of individual grant applications. These 
applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the 
applications, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Ms. Claudia Goad, Committee Management Officer, National Institute 
of Allergy and Infectious Diseases, Solar Building, Room 3C26, National 
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will 
provide a summary of the meeting and a roster of committee members upon 
request. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should contact Ms. Goad in advance of the meeting.
    Dr. Lawrence Deyton, Acting Director, Division of Extramural 
Activities, NIAID, NIH, Solar Building, Room 3C20, 6003 Executive 
Boulevard, Rockville, Maryland 20892, telephone 301-496-7291, will 
provide substantive program information.

(Catalog of Federal Domestic Assistance Program Nos. 93.855 
Immunology, Allergic and Immunologic Diseases Research, 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: December 16, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-33495 Filed 12-23-97; 8:45 am]
BILLING CODE 4140-01-M